123 related articles for article (PubMed ID: 15913868)
1. CANTAB explicit memory is less impaired in addicted schizophrenia patients.
Potvin S; Briand C; Prouteau A; Bouchard RH; Lipp O; Lalonde P; Nicole L; Lesage A; Stip E
Brain Cogn; 2005 Oct; 59(1):38-42. PubMed ID: 15913868
[TBL] [Abstract][Full Text] [Related]
2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
3. Cognitive discernible factors between schizophrenia and schizoaffective disorder.
Stip E; Sepehry AA; Prouteau A; Briand C; Nicole L; Lalonde P; Lesage A
Brain Cogn; 2005 Dec; 59(3):292-5. PubMed ID: 16125294
[TBL] [Abstract][Full Text] [Related]
4. Working memory and multi-tasking in paranoid schizophrenia with and without comorbid substance use disorder.
Thoma P; Daum I
Addiction; 2008 May; 103(5):774-86. PubMed ID: 18412756
[TBL] [Abstract][Full Text] [Related]
5. Processing of social emotion in patients with schizophrenia and substance use disorder: an fMRI study.
Potvin S; Mancini-Marie A; Fahim C; Mensour B; Stip E
Soc Neurosci; 2007; 2(2):106-16. PubMed ID: 18633810
[TBL] [Abstract][Full Text] [Related]
6. Specific cognitive deficits in a group at genetic high risk of schizophrenia.
O'Connor M; Harris JM; McIntosh AM; Owens DG; Lawrie SM; Johnstone EC
Psychol Med; 2009 Oct; 39(10):1649-55. PubMed ID: 19265566
[TBL] [Abstract][Full Text] [Related]
7. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
Chouinard S; Stip E; Poulin J; Melun JP; Godbout R; Guillem F; Cohen H
Curr Med Res Opin; 2007 Mar; 23(3):575-83. PubMed ID: 17355738
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects.
White T; Ho BC; Ward J; O'Leary D; Andreasen NC
Biol Psychiatry; 2006 Sep; 60(5):463-71. PubMed ID: 16566898
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia.
Malhi GS; Ivanovski B; Hadzi-Pavlovic D; Mitchell PB; Vieta E; Sachdev P
Bipolar Disord; 2007; 9(1-2):114-25. PubMed ID: 17391355
[TBL] [Abstract][Full Text] [Related]
10. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
[TBL] [Abstract][Full Text] [Related]
11. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
[TBL] [Abstract][Full Text] [Related]
12. Errorless learning and memory performance in schizophrenia.
Mulholland CC; O'Donoghue D; Meenagh C; Rushe TM
Psychiatry Res; 2008 May; 159(1-2):180-8. PubMed ID: 18423607
[TBL] [Abstract][Full Text] [Related]
13. Impairment of motor dexterity in schizophrenia assessed by a novel finger movement test.
Midorikawa A; Hashimoto R; Noguchi H; Saitoh O; Kunugi H; Nakamura K
Psychiatry Res; 2008 Jun; 159(3):281-9. PubMed ID: 18448171
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
[TBL] [Abstract][Full Text] [Related]
15. Cognitive efficiency in stimulant abusers with and without alcohol dependence.
Lawton-Craddock A; Nixon SJ; Tivis R
Alcohol Clin Exp Res; 2003 Mar; 27(3):457-64. PubMed ID: 12658111
[TBL] [Abstract][Full Text] [Related]
16. Cognition in schizophrenia: impairments, determinants, and functional importance.
Bowie CR; Harvey PD
Psychiatr Clin North Am; 2005 Sep; 28(3):613-33, 626. PubMed ID: 16122570
[TBL] [Abstract][Full Text] [Related]
17. Negative symptoms and specific cognitive impairments as combined targets for improved functional outcome within cognitive remediation therapy.
Greenwood KE; Landau S; Wykes T
Schizophr Bull; 2005 Oct; 31(4):910-21. PubMed ID: 16049165
[TBL] [Abstract][Full Text] [Related]
18. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?
Varga M; Magnusson A; Flekkøy K; David AS; Opjordsmoen S
Compr Psychiatry; 2007; 48(6):583-91. PubMed ID: 17954145
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia.
Mohamed S; Bondi MW; Kasckow JW; Golshan S; Jeste DV
Int J Geriatr Psychiatry; 2006 Aug; 21(8):711-8. PubMed ID: 16862606
[TBL] [Abstract][Full Text] [Related]
20. Behavioural studies of spatial working memory dysfunction in schizophrenia: a quantitative literature review.
Piskulic D; Olver JS; Norman TR; Maruff P
Psychiatry Res; 2007 Mar; 150(2):111-21. PubMed ID: 17292970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
